Verzenio plus Endocrine Therapy Approved for HR-Positive, HER2-Negative, Early-Stage Breast Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 10
- Publication type:
- Article
Works matching IS 21534888 AND DT 2021 AND VI 12 AND IP 6
Results: 11
1
2
The Current and Future State of Medically Integrated Pharmacy in Oncology.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 10
- By:
- Publication type:
- Article
3
Tecentriq Approved for Adjuvant Treatment of Patients with Early-Stage NSCLC and PD-L1 Expression.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 9
- Publication type:
- Article
4
Biosimilars and the Road Ahead.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 9
- By:
- Publication type:
- Article
5
Tivdak First Antibody-Drug Conjugate FDA Approved for Recurrent or Metastatic Cervical Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 8
- Publication type:
- Article
6
FDA Approves Scemblix for 2 Indications in CML.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 8
- Publication type:
- Article
7
Reducing Racial Disparities in Cancer Care.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 8
- By:
- Publication type:
- Article
8
The Impact of Telehealth on Quality, Access, and Cost in Cancer Care.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 1
- By:
- Publication type:
- Article
9
Future-Proofing Cancer Care Against Pandemics.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 1
- By:
- Publication type:
- Article
10
Drug Price Reform with Value in Mind: Is It Possible?
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 1
- By:
- Publication type:
- Article
11
AVBCC Panel Explores Value-Based Contracting in Oncology Care.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 1
- Publication type:
- Article